These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4772055)

  • 21. Incorporation of uridine into ribonucleic acid in rat brain slices after 9 -tetrahydrocannabinol and cannabis.
    Roberge M; Witschi H
    Toxicol Appl Pharmacol; 1972 Nov; 23(3):455-8. PubMed ID: 5085458
    [No Abstract]   [Full Text] [Related]  

  • 22. Increase of serum prolactin in male rats by (minus)-trans-delta9-tetrahydrocannabinol.
    Daley JD; Branda LA; Rosenfeld J; Younglai EV
    J Endocrinol; 1974 Nov; 63(2):415-6. PubMed ID: 4443705
    [No Abstract]   [Full Text] [Related]  

  • 23. Delta9-tetrahydrocannabinol: subcortical spike bursts and motor manifestations in a Fischer rat treated orally for 109 days.
    Stadnicki SW; Schaeppi U; Rosenkrantz H; Braude MC
    Life Sci; 1974 Feb; 14(3):463-72. PubMed ID: 4823985
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of chronic exposure to delta9-tetrahydrocannabinol on delayed matching-to-sample in chimpanzees.
    Ferraro DP; Grilly DM
    Psychopharmacologia; 1974 Jun; 37(4):127-38. PubMed ID: 4844118
    [No Abstract]   [Full Text] [Related]  

  • 25. Some pharmacological effects of phenitrone and its interaction with 9 -THC.
    Spaulding TC; Ford RD; Dewey WL; McMillan DE; Harris LS
    Eur J Pharmacol; 1972 Sep; 19(3):310-7. PubMed ID: 4640854
    [No Abstract]   [Full Text] [Related]  

  • 26. Modification of delta9-THC-actions by cannabinol and cannabidiol in the rat.
    Fernandes M; Schabarek A; Coper H; Hill R
    Psychopharmacologia; 1974; 38(4):329-38. PubMed ID: 4473791
    [No Abstract]   [Full Text] [Related]  

  • 27. Brain levels of delta1-tetrahydrocannabinol and its metabolites in mice tolerant to the hypothermic effect of delta1-tetrahydrocannabinol.
    Lawrence DK; Pertwee RG
    Br J Pharmacol; 1973 Oct; 49(2):373-5. PubMed ID: 4793443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The interaction of delta9-tetrahydrocannabinol and d-amphetamine in aggregated mice.
    Craigmill AL; Canafax DM; Curtiss FR
    Res Commun Chem Pathol Pharmacol; 1974 Oct; 9(2):229-41. PubMed ID: 4438830
    [No Abstract]   [Full Text] [Related]  

  • 29. Task specificity of cross-tolerance between Delta9-tetrahydrocannabinol and anandamide analogs in mice.
    Wiley JL; Smith FL; Razdan RK; Dewey WL
    Eur J Pharmacol; 2005 Mar; 510(1-2):59-68. PubMed ID: 15740725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of the pharmacological activity in man of intravenously administered delta9-tetrahydrocannabinol, cannabinol, and cannabidiol.
    Perez-Reyes M; Timmons MC; Davis KH; Wall EM
    Experientia; 1973 Nov; 29(11):1368-9. PubMed ID: 4761242
    [No Abstract]   [Full Text] [Related]  

  • 31. Acute and subacute interactions between delta9-tetrahydrocannabinol and other drugs in the rat.
    Pryor GT; Husain S; Mitoma C
    Ann N Y Acad Sci; 1976; 281():171-89. PubMed ID: 1071364
    [No Abstract]   [Full Text] [Related]  

  • 32. Differential neurochemistry and temporal pattern in rats treated orally with delta9-tetrahydrocannabinol for periods up to six months.
    Luthra UL; Rosenkrantz H; Heyman IA; Braude MC
    Toxicol Appl Pharmacol; 1975 May; 32(2):418-31. PubMed ID: 1171540
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of delta9-tetrahydrocannabinol on body temperature and brain amine concentrations in the rat at differnt ambient temperatures.
    Fennessy MR; Taylor DA
    Br J Pharmacol; 1977 May; 60(1):65-71. PubMed ID: 884391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions of delta9-tetrahydrocannabinol, adrenal steroids, and ethanol.
    List AF; Bartram SF; Nazar BL
    J Pharm Pharmacol; 1975 Aug; 27(8):606-7. PubMed ID: 239177
    [No Abstract]   [Full Text] [Related]  

  • 35. Lack of tolerance to the bradycardic effect of delta 9-trans-tetrahydrocannabinol in rats.
    Kaymakçalan S; Sivil S
    Pharmacology; 1974; 12(4-5):290-5. PubMed ID: 4449891
    [No Abstract]   [Full Text] [Related]  

  • 36. Chronic delta9-tetrahydrocannabinol in rats: effect on social interactions, mouse killing, motor activity, consummatory behavior, and body temperature.
    Miczek KA
    Psychopharmacology (Berl); 1979 Jan; 60(2):137-46. PubMed ID: 106423
    [No Abstract]   [Full Text] [Related]  

  • 37. Analgesic activity of 9 -tetrahydrocannabinol in the rat and mouse.
    Buxbaum DM
    Psychopharmacologia; 1972; 25(3):275-80. PubMed ID: 5044401
    [No Abstract]   [Full Text] [Related]  

  • 38. 9 -Tetrahydrocannabinol effect on audiogenic seizure susceptibility.
    Boggan WO; Steele RA; Freedman DX
    Psychopharmacologia; 1973 Mar; 29(2):101-6. PubMed ID: 4709834
    [No Abstract]   [Full Text] [Related]  

  • 39. Modification of the effects of 9 -tetrahydrocannabinol by phenobarbital pretreatment in mice.
    Fujimoto JM
    Toxicol Appl Pharmacol; 1972 Dec; 23(4):623-34. PubMed ID: 4644697
    [No Abstract]   [Full Text] [Related]  

  • 40. Tolerance to the effect of delta1-tetrahydrocannabinol on corticosterone levels in mouse plasma produced by repeated administration of cannabis extract or delta1-tetrahydrocannabinol.
    Pertwee RG
    Br J Pharmacol; 1974 Jul; 51(3):391-7. PubMed ID: 4451752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.